These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 498489)

  • 21. Both sublingual and supralingual routes of administration are effective in long-term allergen-specific immunotherapy.
    Panzner P; Petráš M; Sýkora T; Lesná IK; Liška M
    Allergy Asthma Proc; 2011; 32(2):142-50. PubMed ID: 21439167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and immunologic reactivity of patients allergic to grass pollens and to multiple pollen species. I. Clinical and immunologic characteristics.
    Bousquet J; Hejjaoui A; Becker WM; Cour P; Chanal I; Lebel B; Dhivert H; Michel FB
    J Allergy Clin Immunol; 1991 Mar; 87(3):737-46. PubMed ID: 2005328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity.
    Klimek L; Mewes T; Wolf H; Hansen I; Schnitker J; Mann WJ
    Otolaryngol Head Neck Surg; 2005 Oct; 133(4):538-43. PubMed ID: 16213926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy with alginate-conjugated two grass pollen extract in patients with allergic rhinoconjunctivitis.
    Tari MG; Mancino M; Pozzuoli G; Mauro B; Verga A; Monti G
    Allergol Immunopathol (Madr); 1990; 18(1):35-40. PubMed ID: 2382596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Titration of immunotherapy by periodical nasal allergic challenges in the treatment of allergic rhinitis.
    Clarke PS
    Med J Aust; 1992 Jul; 157(1):11-3. PubMed ID: 1640882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and tolerability of seasonal ultra-rush, high-dose sublingual-swallow immunotherapy in allergic rhinitis to grass and tree pollens: an observational study in 193 children and adolescents.
    Seidenberg J; Pajno GB; Bauer CP; La Grutta S; Sieber J
    J Investig Allergol Clin Immunol; 2009; 19(2):125-31. PubMed ID: 19476016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can immunoglobulin E-measurement replace challenge tests in allergic rhinoconjunctivits to grass pollen?
    Huss-Marp J; Darsow U; Brockow K; Pfab F; Weichenmeier I; Schober W; Petersson CJ; Borres MP; Ring J; Behrendt H
    Clin Exp Allergy; 2011 Aug; 41(8):1116-24. PubMed ID: 21518042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo and in vitro characterization of Allpyral grass pollen extracts.
    Kordash TR; Amend MJ; Freshwater LL; Baker RE
    Ann Allergy; 1994 Aug; 73(2):127-33. PubMed ID: 8067596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
    TePas EC; Hoyte EG; McIntire JJ; Umetsu DT
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapy in spring-time hay fever. A clinical and immunological study comparing two different treatment extract compositions.
    Eriksson NE; Ahlstedt S; Lövhagen O
    Allergy; 1979 Aug; 34(4):233-47. PubMed ID: 92897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Grass pollen production and group V allergen content of agriculturally relevant species and cultivars.
    Jung S; Estrella N; Pfaffl MW; Hartmann S; Handelshauser E; Menzel A
    PLoS One; 2018; 13(3):e0193958. PubMed ID: 29529096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High dose grass pollen tablets used for hyposensitization in hay fever patients. A one-year double blind placebo-controlled study.
    Mosbech H; Dreborg S; Madsen F; Ohlsson H; Stahl Skov P; Taudorf E; Weeke B
    Allergy; 1987 Aug; 42(6):451-5. PubMed ID: 3310717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bahia grass pollen, a significant aeroallergen: evidence for the lack of clinical cross-reactivity with timothy grass pollen.
    Phillips JW; Bucholtz GA; Fernandez-Caldas E; Bukantz SC; Lockey RF
    Ann Allergy; 1989 Dec; 63(6 Pt 1):503-7. PubMed ID: 2596759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment.
    Subiza J; Feliú A; Subiza JL; Uhlig J; Fernández-Caldas E
    Clin Exp Allergy; 2008 Jun; 38(6):987-94. PubMed ID: 18445082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nasal immunotherapy in pollen-sensitive children.
    Cserháti E; Mezei G
    Allergy; 1997; 52(33 Suppl):40-4. PubMed ID: 9188948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid.
    Bousquet J; Hejjaoui A; Soussana M; Michel FB
    J Allergy Clin Immunol; 1990 Feb; 85(2):490-7. PubMed ID: 2406327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of glutaraldehyde-modified timothy grass pollen extract in nasal hyposensitisation treatment of hay fever.
    Johansson SG; Deuschl H; Zetterström O
    Int Arch Allergy Appl Immunol; 1979; 60(4):447-60. PubMed ID: 115801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orally administered grass pollen.
    Taudorf E; Weeke B
    Allergy; 1983 Nov; 38(8):561-4. PubMed ID: 6362471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular sensitization patterns and influence of molecular diagnosis in immunotherapy prescription in children sensitized to both grass and olive pollen.
    Martínez-Cañavate Burgos A; Torres-Borrego J; Molina Terán AB; Corzo JL; García BE; Rodríguez Pacheco R; Moreno Aguilar C; Dávila I
    Pediatr Allergy Immunol; 2018 Jun; 29(4):369-374. PubMed ID: 29369414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy.
    Bousquet J; Maasch H; Martinot B; Hejjaoui A; Wahl R; Michel FB
    J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):439-46. PubMed ID: 3170992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.